Read More 31 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 6:02 PM On Friday, 497 companies set new 52-week lows. AADI
Read More 4 minute read Options Stocks That Hit 52-Week Lows On Monday By Benzinga Insights Today, 6:02 PM During Monday's session, 56 companies made new 52-week lows. AMRS
Read More 9 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 6:02 PM On Friday, 135 companies reached new 52-week lows. AFMD
Read More 3 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 6:02 PM During Friday, 48 stocks hit new 52-week lows. ABEV
Read More 1 minute read News Penny Stocks Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines By Charles Gross Today, 6:02 PM GreenLight Biosciences Holdings, PBC (Nasdaq: GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers. GRNA
Read More 4 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket By Lisa Levin Today, 6:02 PM Gainers AEMD
Read More 1 minute read Movers 12 Health Care Stocks Moving In Friday’s After-Market Session By Benzinga Insights Today, 6:02 PM Gainers Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday’s after-market session. The market value of their outstanding… ADAP
Read More 9 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights Today, 6:02 PM On Friday, 127 companies set new 52-week lows. $APE
Read More 10 minute read News Options Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights Today, 6:02 PM During Tuesday's trading, 160 companies set new 52-week lows. ABSI
Read More 1 minute read Earnings News GreenLight Biosciences Q3 EPS $(0.27), Sales $1.73M By Michael Horton Today, 6:02 PM GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.27) per share. The company reported $1.73 million in sales this quarter. GRNA